Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,593.20
(
1.00%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
94.87
(
-1.69%
)
Bitcoin
71,528.99
(
1.43%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 116047

Tuesday, 04/16/2019 11:30:54 AM

Tuesday, April 16, 2019 11:30:54 AM

Post# of 257275
OPHT—>ISEE (Iveric Bio) at the open tomorrow:

https://www.businesswire.com/news/home/20190416005282/en

“We are excited about our re-branding and corporate name change reflecting our transition to a gene therapy focused company developing treatments for patients with orphan inherited retinal diseases,” stated Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC bio.

In other words, they don’t want investors to be reminded of the Fovista failures.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today